Zonule Assembly and Ectopia Lentis

小带组装和异位晶状体

基本信息

  • 批准号:
    8435502
  • 负责人:
  • 金额:
    $ 29.56万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-03-01 至 2016-02-29
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The central position of the lens in the optic path as well as accommodation, rely on the zonule of Zinn, an acellular fibrous structure, which has fibrillin-1 as a major component. Ectopia lentis, dislocation of the lens, is a major manifestation of the Marfan syndrome (MFS), a common genetic disorder caused by dominantly inherited FBN1 mutations, of Weill-Marchesani syndrome (caused by FBN1, ADAMTS10 and ADAMTS17 mutations), and isolated ectopia lentis (caused by ADAMTSL4 or FBN1 mutations). These genetic findings strongly suggest a functional link between these ADAMTS (A distintegrin-like and metalloprotease with thrombospondin type-1 repeat) superfamily molecules and fibrillin-1, about which little is known. The hypothesis underlying the proposal is that ADAMTSL4, ADAMTS10 and ADAMTS17 are esential for microfibril assembly in the zonule of Zinn as this structure organizes and bridges the ciliary body and lens. In this proposal, focusing on ADAMTS17 and ADAMTSL4, we will undertake intermolecular interaction analysis using surface plasmon resonance to investigate their individual intermolecular interactions of with fibrillin-1. We will investigate them functionally during fibrillin microfibril formation by cultured cells, and determine whether ADAMTSL4, fibrillin-1 or ADAMTS10 are ADAMTS17 substrates. We will investigate a model in which ADAMTS17, ADAMTSL4 and ADAMTS10 are postulated to work cooperatively to facilitate assembly of the zonule, and investigate the spatial and temporal relationships of the expression of these genes during zonule development. This experimental strategy will reveal the biochemical and functional relationships of ADAMTSL4 and ADAMTS17 with fibrillin-1 and ADAMTS10. It will provide a mechanistic understanding of zonule formation and the cause of ectopia lentis. There is currently no specific treatment for ectopia lentis. The fundamental knowledge obtained through this work may allow design of novel therapeutic approaches for ectopia lentis by identifying the critical factors and mechanisms that mediate zonule assembly and stability.
描述(由申请人提供):晶状体在光路中的中心位置以及调节依赖于Zinn的带状,Zinn是一种脱细胞纤维结构,其主要成分是纤原蛋白-1。晶状体异位,即晶状体脱位,是马凡综合征(MFS)、weil - marchesani综合征(由FBN1、ADAMTS10和ADAMTS17突变引起)和孤立性晶状体异位(由ADAMTSL4或FBN1突变引起)的主要表现。马凡综合征是一种常见的遗传性疾病,主要由FBN1突变引起。这些遗传发现强烈表明,这些ADAMTS(一种具有凝血蛋白1型重复的分离整合素样和金属蛋白酶)超家族分子与纤原蛋白1之间存在功能联系,对此知之甚少。该提议的假设是ADAMTSL4, ADAMTS10和ADAMTS17对于Zinn带中的微纤维组装是必不可少的,因为该结构组织和连接睫状体和晶状体。在本研究中,我们将以ADAMTS17和ADAMTSL4为研究对象,利用表面等离子体共振进行分子间相互作用分析,研究它们与fibrin -1的分子间相互作用。我们将研究它们在培养细胞形成原纤维微纤维过程中的功能,并确定ADAMTSL4、fibrin -1或ADAMTS10是否为ADAMTS17底物。我们将研究ADAMTS17、ADAMTSL4和ADAMTS10协同工作以促进区域规则组装的模型,并研究这些基因在区域规则发育过程中的表达时空关系。该实验策略将揭示ADAMTSL4和ADAMTS17与纤原蛋白1和ADAMTS10的生化和功能关系。它将提供一个机制的理解带状的形成和原因的异位晶状体。目前还没有针对异位晶状体的特殊治疗方法。通过这项工作获得的基础知识可以通过确定调节区组装和稳定性的关键因素和机制来设计新的治疗方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUNEEL S APTE其他文献

SUNEEL S APTE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUNEEL S APTE', 18)}}的其他基金

The proteolytic landscape of osteoarthritic cartilage
骨关节炎软骨的蛋白水解景观
  • 批准号:
    10606642
  • 财政年份:
    2022
  • 资助金额:
    $ 29.56万
  • 项目类别:
The proteolytic landscape of osteoarthritic cartilage
骨关节炎软骨的蛋白水解景观
  • 批准号:
    10370498
  • 财政年份:
    2022
  • 资助金额:
    $ 29.56万
  • 项目类别:
Proteoglycan dynamics in pathogenesis of thoracic aortic aneurysm and dissection
胸主动脉瘤和夹层发病机制中的蛋白多糖动力学
  • 批准号:
    9769293
  • 财政年份:
    2018
  • 资助金额:
    $ 29.56万
  • 项目类别:
Extracellular matrix remodeling in ocular anterior segment development
眼前节发育中的细胞外基质重塑
  • 批准号:
    8798380
  • 财政年份:
    2014
  • 资助金额:
    $ 29.56万
  • 项目类别:
Extracellular matrix remodeling in ocular anterior segment development
眼前节发育中的细胞外基质重塑
  • 批准号:
    9189617
  • 财政年份:
    2014
  • 资助金额:
    $ 29.56万
  • 项目类别:
American Society for Matrix Biology Biennial Meeting 2014
2014 年美国基质生物学学会双年会
  • 批准号:
    8785810
  • 财政年份:
    2014
  • 资助金额:
    $ 29.56万
  • 项目类别:
2013 Matrix Metalloproteinase Gordon Research Conference and Gordon Research Semi
2013年基质金属蛋白酶戈登研究会议及戈登研究半会
  • 批准号:
    8511050
  • 财政年份:
    2013
  • 资助金额:
    $ 29.56万
  • 项目类别:
Zonule Assembly and Ectopia Lentis
小带组装和异位晶状体
  • 批准号:
    8625306
  • 财政年份:
    2011
  • 资助金额:
    $ 29.56万
  • 项目类别:
Endothelial protease activity, organogenesis and birth defects
内皮蛋白酶活性、器官发生和出生缺陷
  • 批准号:
    8318871
  • 财政年份:
    2011
  • 资助金额:
    $ 29.56万
  • 项目类别:
Endothelial protease activity, organogenesis and birth defects
内皮蛋白酶活性、器官发生和出生缺陷
  • 批准号:
    8177298
  • 财政年份:
    2011
  • 资助金额:
    $ 29.56万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 29.56万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 29.56万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.56万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.56万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 29.56万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.56万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 29.56万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 29.56万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 29.56万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.56万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了